Research [ASAP] Tunable Drug Release through Varying Drug Affinities for Ocular Chronic Disease LikeLiked Date: June 18, 2025 Less than 1 MinRead Views: 41 ACS Applied Bio Materials DOI: 10.1021/acsabm.5c00425 Source: http://dx.doi.org/10.1021/acsabm.5c00425 Tags:Materials Industry FacebookTwitterLinkedinWhatsAppTelegramEmail ALT-Lab-Ad-1ALT-Lab-Ad-2ALT-Lab-Ad-3ALT-Lab-Ad-4ALT-Lab-Ad-5ALT-Lab-Ad-6ALT-Lab-Ad-7ALT-Lab-Ad-8ALT-Lab-Ad-9ALT-Lab-Ad-10ALT-Lab-Ad-11ALT-Lab-Ad-12ALT-Lab-Ad-13 Recent Articles Google Commits $60 Million to Water Projects as AI Data Center Demand Grows Carbon Markets August 24, 2026 🌎 Volts meet midterm votes #310 Finance & investments August 24, 2026 U.S. DOE Invests $500 Million in Critical Mineral, Battery Supply Chain Projects Environmental News August 24, 2026 AI platform aims to transform solar site assessment Solar Power August 24, 2026 World Bank Issues $4 Billion Sustainable Development Bond Environmental News August 24, 2026 Solar Power August 24, 2026 One of the World’s ‘Most Wanted’ Lost Fish Is Rediscovered Environmental News August 24, 2026 The Purple Fabric That Could Beat the Scorching Heat Research August 24, 2026 Two ABB Optical Scientists Join SPIE’s Elite, Highlighting Québec’s Optical Innovation Research August 24, 2026 Ag misinformation, tackling the ‘bro club’ and more: In conversation with the 2026 Influential Women in Canadian Agriculture Food & Agriculture August 24, 2026 Load more
